Lithium causing a serious sinus-node dysfunction at therapeutic doses.

G Montalescot; Y Levy; D Farge; L Brochard; B Fantin; C Arnoux; P Y Hatt

doi:10.1002/clc.4960071113

PubMed · 6437719

Lithium causing a serious sinus-node dysfunction at therapeutic doses.

G Montalescot·Y Levy·D Farge·L Brochard·B Fantin·C Arnoux·P Y Hatt

View original source ↗Export metadata ↓

Abstract

The cardiovascular effects of lithium have been indexed in literature since 1900, most frequently in cases of intoxication. We recently studied the exceptional case of a patient showing a serious sinus node dysfunction during lithium treatment. The serum lithium levels were always within the therapeutic range. After two endocardial explorations and withdrawal of lithium, we found that the sinus node dysfunction was due to lithium and reversible after withdrawal of it. Some ignored dysfunctions could exist with a regularly controlled treatment.

Explore related subjects

Ajmaline Arrhythmia, Sinus Bipolar Disorder Bradycardia Cardiac Pacing, Artificial Electrocardiography Humans Lithium Lithium Carbonate Male Middle Aged Sinoatrial Node Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

G Montalescot, Y Levy, D Farge, L Brochard, B Fantin, C Arnoux, P Y Hatt. 1984. Lithium causing a serious sinus-node dysfunction at therapeutic doses.. https://doi.org/10.1002/clc.4960071113

Cite the original work for its findings. Save a collection to share your selection of sources.

Lithium causing a serious sinus-node dysfunction at therapeutic doses.

Abstract

Explore related subjects

Keep this discovery

Related citations

General approach for the synthesis of sarpagine/ajmaline indole alkaloids. Stereospecific total synthesis of the sarpagine alkaloid (+)-vellosimine.

Interpretation of the formation of nine "artifact indole alkaloids" in the ajmaline/sarpagine series.

The structure of the ring-opened N beta-propyl-ajmaline (Neo-Gilurytmal) at physiological pH is obviously responsible for its better absorption and bioavailability when compared with ajmaline (Gilurytmal).